These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 23424730)
21. Rapid impact of rotavirus vaccination in the United States: implications for Australia. Macartney KK; Burgess MA Med J Aust; 2009 Aug; 191(3):131-2. PubMed ID: 19645636 [TBL] [Abstract][Full Text] [Related]
22. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Parashar UD; Alexander JP; Glass RI; MMWR Recomm Rep; 2006 Aug; 55(RR-12):1-13. PubMed ID: 16902398 [TBL] [Abstract][Full Text] [Related]
23. Rotavirus vaccines: update on global impact and future priorities. Yen C; Tate JE; Patel MM; Cortese MM; Lopman B; Fleming J; Lewis K; Jiang B; Gentsch J; Steele D; Parashar UD Hum Vaccin; 2011 Dec; 7(12):1282-90. PubMed ID: 22108032 [TBL] [Abstract][Full Text] [Related]
24. Evaluating the potential risks and benefits of infant rotavirus vaccination in England. Clark A; Jit M; Andrews N; Atchison C; Edmunds WJ; Sanderson C Vaccine; 2014 Jun; 32(29):3604-10. PubMed ID: 24814524 [TBL] [Abstract][Full Text] [Related]
25. Introduction of rotavirus vaccine in Pakistan - the need to be vigilant for intestinal intussusception in children - letter to the editor. Siddiqi R; Memon RS; Ahmed H J Pak Med Assoc; 2019 Jun; 69(6):925-926. PubMed ID: 31201412 [No Abstract] [Full Text] [Related]
27. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. Bresee JS; Hummelman E; Nelson EA; Glass RI J Infect Dis; 2005 Sep; 192 Suppl 1():S1-5. PubMed ID: 16088790 [No Abstract] [Full Text] [Related]
28. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil. Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692 [TBL] [Abstract][Full Text] [Related]
29. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223 [TBL] [Abstract][Full Text] [Related]
30. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine. Grant L; Watt J; Moulton L; Weatherholtz R; Reid R; Santosham M; O'Brien K J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):635-40. PubMed ID: 23343932 [TBL] [Abstract][Full Text] [Related]
37. Impact of rotavirus vaccines on rotavirus disease. Lepage P; Vergison A Expert Rev Anti Infect Ther; 2012 May; 10(5):547-61. PubMed ID: 22702319 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece. Syriopoulou V; Kafetzis D; Theodoridou M; Syrogiannopoulos GA; Mantagos S; Trimis G; Mavrikou M; Konstantopoulos A Acta Paediatr; 2011 May; 100(5):732-9. PubMed ID: 21223372 [TBL] [Abstract][Full Text] [Related]
39. Rotavirus vaccines. Simonsen L; Taylor RJ; Kapikian AZ N Engl J Med; 2006 Apr; 354(16):1747-51; author reply 1747-51. PubMed ID: 16625742 [No Abstract] [Full Text] [Related]
40. Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. Weycker D; Sofrygin O; Kemner JE; Pelton SI; Oster G Vaccine; 2009 Aug; 27(36):4930-7. PubMed ID: 19555715 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]